EICHORCondition: Prader-Willi Syndrome · Sponsor: Harmony Biosciences Management, Inc.
The primary objective of this study is to evaluate the safety and efficacy of pitolisant compared with placebo in treating excessive daytime sleepiness (EDS) in patients with Prader Willi syndrome (PWS) ages 6 to 65 years.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Rady Children's Hospital - San Diego | San Diego, California, United States | — |
| Sleep Medicine Specialists of California | San Ramon, California, United States | — |
| Santa Monica Clinical Trials | Santa Monica, California, United States | — |
| Children's Hospital Colorado | Aurora, Colorado, United States | — |
| Nemours Alfred I duPont Hospital for Children | Wilmington, Delaware, United States | — |
| University of Florida College of Medicine | Gainesville, Florida, United States | — |
| Ann and Robert H Lurie Children's Hospital | Chicago, Illinois, United States | — |
| Johns Hopkins School of Medicine | Baltimore, Maryland, United States | — |
| University of Nebraska Medical Center | Omaha, Nebraska, United States | — |
| CTI | Cincinnati, Ohio, United States | — |
| Vanderbilt University Medical Center | Nashville, Tennessee, United States | — |
| Texas Children's Hospital/Baylor College of Medicine | Houston, Texas, United States | — |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04257929